We are live on ! Find out more
AVNS icon

Avanos Medical

299 hedge funds and large institutions have $1.42B invested in Avanos Medical in 2022 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 97 increasing their positions, 70 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,217% more call options, than puts

Call options by funds: $679K | Put options by funds: $6K

39% more repeat investments, than reductions

Existing positions increased: 97 | Existing positions reduced: 70

22% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 32

1.86% more ownership

Funds ownership: 91.06%92.93% (+1.9%)

1% more funds holding

Funds holding: 297299 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less capital invested

Capital invested by funds: $1.52B → $1.42B (-$98M)

Holders
299
Holders Change
+2
Holders Change %
+0.67%
% of All Funds
4.72%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
39
Increased
97
Reduced
70
Closed
32
Calls
$679K
Puts
$6K
Net Calls
+$673K
Net Calls Change
-$1.4M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$255M +$22.2K +688 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$179M +$3.62M +112,546 +2%
RC
3
RGM Capital
Florida
$99.1M +$862K +26,753 +0.9%
PIM
4
Paradice Investment Management
Colorado
$82.4M -$22.5M -698,048 -22%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$79.3M +$8.73M +271,105 +13%
State Street
6
State Street
Massachusetts
$67.6M +$303K +9,410 +0.5%
Goldman Sachs
7
Goldman Sachs
New York
$67M +$12.7M +392,870 +24%
WHG
8
Westwood Holdings Group
Texas
$36.1M +$121K +3,771 +0.4%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$30.1M +$4M +124,254 +16%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$28.1M +$722K +22,417 +3%
Neuberger Berman Group
11
Neuberger Berman Group
New York
$27.5M -$429K -13,333 -2%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$24.2M -$19.5M -604,599 -46%
Millennium Management
13
Millennium Management
New York
$23.2M +$12.2M +379,705 +121%
Northern Trust
14
Northern Trust
Illinois
$21.4M -$333K -10,345 -2%
N
15
Nuveen
North Carolina
$19.1M -$676K -20,997 -3%
Charles Schwab
16
Charles Schwab
California
$18.6M +$3.95M +122,601 +28%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$18.5M -$47.8K -1,483 -0.3%
TCM
18
Tributary Capital Management
Nebraska
$18M +$853K +26,487 +5%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$17.5M +$98K +3,044 +0.6%
Morgan Stanley
20
Morgan Stanley
New York
$15.4M +$7.6M +236,066 +106%
Norges Bank
21
Norges Bank
Norway
$15.1M
Ameriprise
22
Ameriprise
Minnesota
$12.5M -$20.4K -634 -0.2%
Principal Financial Group
23
Principal Financial Group
Iowa
$12.3M -$709K -22,006 -6%
AIMCA
24
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$11.7M -$946K -29,371 -8%
HA
25
Heartland Advisors
Wisconsin
$11.7M +$13.4K +417 +0.1%

AVNS Hedge Fund Activity: Q1 2022 in Review

299 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2022, worth a combined $1.42B — down 6.4% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new AVNS positions and 32 closed out — a net gain of 7 holders — while 97 added to existing stakes and 70 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $12.7M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $40.7M sold.

  • 299 institutional investors held Avanos Medical (AVNS) as of Q1 2022, up from 297 in Q4 2021.
  • Funds reported $1.42B of Avanos Medical stock for Q1 2022, down 6.4% quarter-over-quarter.
  • 39 funds opened new Avanos Medical positions in Q1 2022 and 32 closed out, a net change of +7 holders.
  • The largest Avanos Medical buyer in Q1 2022 was Goldman Sachs, an estimated $12.7M added.
  • The largest Avanos Medical seller in Q1 2022 was Champlain Investment Partners, an estimated $40.7M sold.

Based on aggregated 13F filings for Q1 2022.